I just finished watching the Netflix documentary called

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
348
I just finished watching the Netflix documentary called 'Facing Nolan'. Of course, it's about Nolan Ryan, who pitched his 7th no-hitter at the age of 44. His career was bumpy at first, wild pitches, walks, etc. but he had the goods and when he got some real coaching his career took off. Interestingly, and this is great trivia question, he never won a Cy Young award. Hard to imagine anyone else matching his career. Pitching in the 108 mph range, The Ryan Express was a force to be reckoned with, no doubt.

Bioelectronics, BIEL, has yet to crack the professional sports world in any meaningful way. As far as I am concerned we should, ALREADY!!!, have been in every sports locker room the world over years and years ago. The reasons for this are deep, dark, not-so-mysterious, and not worth the words to give it justice. It is criminal if we lived in a sane world, which we most certainly do not. Truth be told, we celebrate insanity, give each other awards for petty accomplishments and declare ourselves civilized. Oh, how beautiful the emperor's new clothes!

Set aside the fact that our budget will not afford a monster advertising campaign, the reputation of this 'miracle' device should have spread far and wide on how effective it is, and with no side effects, ever. Something this good, and easy to use, and affordable has star power all on its' own. Let the athletes perform w/o all the bullshit politics, the insane amounts of money (ref: $230 million guaranteed contract for a qb on an 8 game suspension ???), the gambling, the hype, the elitism (take your kid to a game and spend how much?), the corruption and point shaving, sports has become more Vegas showtime and less competition. We, BIEL, have been 'in the game' for 20 yrs and we get excited by brief exposure on a nauseating morning talk show.

I remember Nolan Ryan's career and how, time after time, teams underrated him. Repeatedly, his career was over. He pitched 2 more no-hitters after turning 40. He persevered b/c he alone knew Nolan Ryan better than anybody. Likewise, our Founder, Andy Whelan persevered b/c he knew the PEMF technology as well as, if not better than most. He endured the slings and arrows of outrageous aggression. BIEL has been ridiculed, scoffed and sneered at, written off, always to come back even better. So, piss off, bashers and boneheads, big pharma, FDA, and anybody else standing in our way. We are taking the cue from the Ryan Express and we are gaining speed. The best hitters in baseball whiffed his fast ball. The filthy liars and nastiest deceivers who pulled every dirty trick in the book are going down. We are coming; we are many; and We are Legion.

Yea, feeling a little feisty these days. And why the hell not? Stand up, say what you think. Better yet, THINK! Practice random logic and point out the absurdity of gulping down bottles of poison b/c some idiot on tv said so. I work w/ a guy, who at the age of 54 takes 13 pills per day and sees no other way. Another guy takes over 20; same attitude. These sad cases don't happen by accident, quite the opposite. It is intentional and must change or we shall surely perish mistaking the dancing shadows for reality.

You all know what I want to happen in the near future so I'll spare you another rendition. This investment means more than money to me. I still talk about it, like this past week, to 2 young truck drivers, both having lower back pain and not knowing about an alternative to pills. I did them a favor and felt great about it. I might fail in this investment but I'll fight to the finish knowing what the stakes are and what we are up against. I'll leave you w/ a great quote attributed to Teddy Roosevelt.
Quote:
"It is not the critic who counts; not the man who points out how the strong man stumbles, or where the doer of deeds could have done them better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood; who strives valiantly; who errs, who comes short again and again, because there is no effort without error and shortcoming; but who does actually strive to do the deeds; who knows great enthusiasms, the great devotions; who spends himself in a worthy cause; who at the best knows in the end the triumph of high achievement, and who at the worst, if he fails, at least fails while daring greatly, so that his place shall never be with those cold and timid souls who neither know victory nor defeat."

"Sic parvis magma" - Greatness from small beginnings
definitely BUY_MORE_SHARES

later, WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 3

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 4

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 3

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 2

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 4

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

Liberty Energy Inc. Details Upcoming Financial Results Call

Updated Category News Views 123

Liberty Energy Inc. to Announce Key Financial Outcomes Liberty Energy Inc. (NYSE: LBRT) is preparing to release its financial results for the fourth quarter and full year ending December 31, 2024, just after market close on January 29, 2025. This key announcement will eagerly be anticipated by investors and market analysts alike. Conference Call to Discuss Financial...

Continue Reading
Cambridge Achieves Major Revenue Mark of Over $2 Billion

Updated Category News Views 283

Cambridge Achieves Significant Revenue Milestone Cambridge Investment Research, Inc., a notable player in financial solutions, has recently announced a groundbreaking accomplishment: surpassing $2 billion in annual revenue for the first time. This impressive feat showcases the company's remarkable growth over a short duration, doubling its revenue in just five years. A...

Continue Reading
Elon Musk's Generous Gesture: Free Starlink Terminals for Victims

Updated Category News Views 453

Elon Musk's Commitment to Supporting Wildfire Victims SpaceX CEO Elon Musk recently announced his company’s plan to provide free Starlink terminals to regions experiencing the devastating effects of wildfires. This compassionate initiative aims to support affected communities as they navigate through challenging times. Details of the Initiative In a recent post on his...

Continue Reading
Elevating Leadership at Know Labs for Innovative Solutions

Updated Category News Views 68

Elevating Leadership at Know Labs for Innovative Solutions Know Labs, Inc. (NYSE American: KNW), a pioneering entity in non-invasive diagnostic technology, has announced the addition of two significant leaders to its executive team. John Cronin is stepping into the role of Interim Chief Technology Officer, while Dominic Klyve, Ph.D., will serve as the Chief Science...

Continue Reading
Centrus Energy's New Funding Boosts Advanced Nuclear Projects

Updated Category News Views 176

Critical Funding for Advanced Nuclear Fuel Supply In a significant move towards strengthening the nuclear energy sector, Centrus Energy has announced that its subsidiary, American Centrifuge Operating, LLC, has secured an important award from the U.S. Department of Energy. This funding is dedicated to deploying cutting-edge technology and equipment aimed at converting...

Continue Reading